Congratulations to Dr. Pamela Hoodless for receiving a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC).
Dr. Hoodless, a distinguished researcher and Interim Head, Basic and Translational Research at BC Cancer, will use the grant to support her work in defining cell lineages and plasticity in the developing liver.
British Columbia’s first dedicated inpatient clinical trials unit for early-phase therapies in blood cancers has been launched by Vancouver Coastal Health in collaboration with BC Cancer physicians and scientists. Located at Vancouver General Hospital (VGH), the new Hematology Research Unit will deliver revolutionary therapies — including first-in-human treatments such as advanced immunotherapies like CAR T-cell therapy — to patients with relapsed or treatment-resistant hematological diseases.
Congratulations to the recipients of the BC Cancer Foundation (BCCF) 2024 Rising Stars Award competition!
This year’s awardees are:
BC Cancer researchers receive Cancer Research Society’s Doctoral Research Awards
Three BC Cancer graduate students are 2024 recipients of Doctoral Research Awards from the Cancer Research Society (CRS), receiving new funding to support their innovative research aimed at better understanding cancer.
Doctoral Research Awards recipients
Doctoral Research Awards invests in the future of cancer research through the support of graduate students pursuing cancer research at an eligible Canadian institution.
BC Cancer’s 2024 Cancer Emerging Multidisciplinary Research Programs supports research teams to initiate novel multidisciplinary research projects that aim to tackle well-defined issues or problems that affect patients living with cancer or at risk of developing cancer. Funding for the programs is provided through the BC Ministry of Health in collaboration with the BC Cancer Foundation.
2024 Emerging Multidisciplinary Research Programs Recipients:
Congratulations to Lorenzo Lindo of Hay Lab (Terry Fox Laboratory) for receiving a Canadian Cancer Society (CCS) Research Training Award, with joint funding from the Terry Fox Research Institute (TFRI).
The award is tied to the project titled, "Engineering CAR-T Cells to Overcome Immune Suppression and Enhance Efficacy in Multiple Myeloma.”
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.